Export

EN
FR
Clofazimine
Essential medicine status
Section:
6. Anti-infective medicines 6.2. Antibacterials 6.2.4. Antileprosy medicines
ATC codes: J04BA01
EMLc
Indication
Leprosy ICD11 code: 1B50.Z
INN
Clofazimine
Medicine type
Chemical agent
List type
Core (EML)
(EMLc)
Additional notes
Medicines used in the treatment of leprosy should never be used except in combination. Combination therapy is essential to prevent the emergence of drug resistance. Colour-coded blister packs (MDT blister packs) containing standard two-medicine (paucibacillary leprosy) or three-medicine (multibacillary leprosy) combinations for adult and childhood leprosy should be used. MDT blister packs can be supplied free of charge through WHO.
Formulations
Oral > Solid: 100 mg ; 50 mg
EML status history
First added in 1977 (TRS 615)
Changed in 1982 (TRS 685)
Changed in 1984 (TRS 722)
Changed in 2003 (TRS 920)
Changed in 2007 (TRS 946)
Changed in 2019 (TRS 1021)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
Clofazimine
DrugBank
Clofazimine
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended an amendment to the dosage form terminology for clofazimine, replacing 'capsule' with 'solid oral dosage form'.